We are live on ! Find out more
NRS

Neville Rodie & Shaw Portfolio holdings

AUM $1.55B
1-Year Est. Return 46.95%
This Fund
S&P 500
This Quarter Est. Return
+8.88%
1 Year Est. Return
+46.95%
3 Year Est. Return
+114.59%
5 Year Est. Return
+149.24%
10 Year Est. Return
+498%
AUM
$1.02B
AUM Growth
+$74.7M
Cap. Flow
-$986K
Cap. Flow %
-0.1%
Top 10 Hldgs %
31.61%
Holding
254
New
10
Increased
66
Reduced
77
Closed
4

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$5.43M
2
QCOM icon
Qualcomm
QCOM
+$1.65M
3
BX icon
Blackstone
BX
+$1.52M
4
DIS icon
Walt Disney
DIS
+$869K
5
ZTS icon
Zoetis
ZTS
+$790K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$9.24M
2
BA icon
Boeing
BA
+$1.45M
3
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
+$1.35M
4
XOM icon
ExxonMobil
XOM
+$1.3M
5
AGN
Allergan plc
AGN
+$1.01M

Sector Composition

Rank Sector Weight
1 Healthcare 20.13%
2 Technology 16.35%
3 Financials 15.15%
4 Industrials 12.69%
5 Energy 8.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZBH icon
126
Zimmer Biomet
ZBH
$18.4B
$886K 0.09%
6,102
-72
-1% -$9.94K
CET
127
Central Securities Corp
CET
$1.65B
$858K 0.08%
25,925
– –
ITW icon
128
Illinois Tool Works
ITW
$84.5B
$847K 0.08%
4,717
– –
ROK icon
129
Rockwell Automation
ROK
$49B
$831K 0.08%
4,100
– –
COF icon
130
Capital One
COF
$134B
$801K 0.08%
7,783
– –
TROW icon
131
T. Rowe Price
TROW
$24.3B
$740K 0.07%
6,075
– –
GWW icon
132
W.W. Grainger
GWW
$60.2B
$738K 0.07%
2,179
– –
EQR icon
133
Equity Residential
EQR
$25.1B
$728K 0.07%
9,000
– –
TT icon
134
Trane Technologies
TT
$106B
$718K 0.07%
5,400
– –
FDX icon
135
FedEx
FDX
$75.4B
$714K 0.07%
4,724
-313
-6% -$48.2K
HSIC icon
136
Henry Schein
HSIC
$9.82B
$714K 0.07%
10,700
– –
A icon
137
Agilent Technologies
A
$41.2B
$694K 0.07%
8,128
– –
CMCSA icon
138
Comcast
CMCSA
$90B
$693K 0.07%
15,412
+4
+0% +$178
MO icon
139
Altria Group
MO
$114B
$683K 0.07%
13,675
-875
-6% -$41.3K
NUE icon
140
Nucor
NUE
$62.1B
$681K 0.07%
12,094
-175
-1% -$9.54K
DOV icon
141
Dover
DOV
$28.4B
$661K 0.06%
5,732
– –
ETN icon
142
Eaton
ETN
$174B
$648K 0.06%
6,850
– –
RSPD icon
143
Invesco S&P 500 Equal Weight Consumer Discretionary ETF
RSPD
$337M
$645K 0.06%
+17,400
New +$622K
ACAD icon
144
Acadia Pharmaceuticals
ACAD
$5.03B
$642K 0.06%
15,000
– –
KNX icon
145
Knight Transportation
KNX
$11.4B
$613K 0.06%
17,100
– –
WMB icon
146
Williams Companies
WMB
$86.1B
$612K 0.06%
25,776
– –
ROP icon
147
Roper Technologies
ROP
$39.8B
$609K 0.06%
1,720
– –
OKE icon
148
Oneok
OKE
$54.5B
$606K 0.06%
8,010
– –
AEP icon
149
American Electric Power
AEP
$68.4B
$603K 0.06%
6,383
– –
UHT
150
Universal Health Realty Income Trust
UHT
$594M
$596K 0.06%
5,075
– –
4 5
6
7 8

Similar funds

BGCP
Bristol Gate Capital Partners Toronto, Ontario, Canada $1.55B AUM 12.75% 1-Year Est. Return
MSA
MUFG Securities Americas New York $1.55B AUM 28.4% 1-Year Est. Return
CET
Clean Energy Transition London, United Kingdom $1.54B AUM 34.41% 1-Year Est. Return
ICM
Irenic Capital Management New York $1.54B AUM 12.79% 1-Year Est. Return
CCM
Cinctive Capital Management New York $1.53B AUM 48.83% 1-Year Est. Return
TNBTD
Trustmark National Bank Trust Department Jackson, Mississippi $1.56B AUM 16.53% 1-Year Est. Return
MCP
Meridiem Capital Partners Dallas, Texas $1.53B AUM 17.03% 1-Year Est. Return
SG
Sienna Gestion Paris, France $1.53B AUM 27.73% 1-Year Est. Return

Neville Rodie & Shaw's Q4 2019 Portfolio in Review

As of Q4 2019, Neville Rodie & Shaw held 254 positions worth $1.02B, up 7.9% from $945M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Neville Rodie & Shaw's Q4 2019 filing shows 10 new, 66 increased, 77 reduced and 4 closed positions. Its largest new stake was Qualcomm: 19,730 shares worth $1.74M. The largest sale was Celgene Corp, an estimated $9.24M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.

  • Neville Rodie & Shaw's largest Q4 2019 buy was Qualcomm: 19,730 shares worth $1.74M.
  • Neville Rodie & Shaw added most to Bristol-Myers Squibb in Q4 2019, an estimated $5.43M increase.
  • Neville Rodie & Shaw's biggest Q4 2019 reduction was Boeing, cutting an estimated $1.45M.
  • Neville Rodie & Shaw fully exited Celgene Corp in Q4 2019, selling an estimated $9.24M.
  • Neville Rodie & Shaw's ten largest holdings make up 32% of its $1.02B portfolio in Q4 2019.
  • Neville Rodie & Shaw opened 10 new positions and closed 4 in Q4 2019.
  • Neville Rodie & Shaw's portfolio value rose 7.9% quarter-over-quarter to $1.02B.

Based on Neville Rodie & Shaw's 13F filing for Q4 2019, filed 8 Jan 2020.